RESUMO
OBJECTIVE: To assess the main performance indicators of neurosurgical departments in surgical treatment of cerebral aneurysms in the Russian Federation. MATERIAL AND METHODS: We analyzed 22 neurosurgical departments (19 regional and 3 federal hospitals) in 2017 and 2021. The study enrolled 6.135 patients including 3.160 ones in 2017 and 2.975 ones in 2021. We studied the features of surgical treatment of cerebral aneurysms in different volume hospitals and factors influencing postoperative outcomes. RESULTS: The number of surgeries for cerebral aneurysms decreased from 2.950 in 2017 to 2.711 in 2021. Postoperative mortality rate was 6.3% and 5.6%, respectively. The number of microsurgical interventions decreased from 60% in 2017 to 48% in 2021. The share of endovascular interventions increased from 40% to 52%, respectively. Endovascular embolization was accompanied by stenting in 55% of cases. Simultaneous revascularization was carried out in 2% of cases. In 2021, the number of patients undergoing surgery in acute period of hemorrhage increased to 70% (in 2017 - 61%). The number of hospitals performing more than 50 surgical interventions for cerebral aneurysms annually increased from 14 in 2017 to 17 in 2021. CONCLUSION: Certain changes in neurosurgical service occurred in 2021 compared to 2017. Lower number of surgical interventions for cerebral aneurysms, most likely caused by the COVID-19 pandemic, is accompanied by lower postoperative mortality. Endovascular interventions and revascularization techniques became more common. The number of surgeries in acute period after aneurysm rupture and hospitals performing more than 50 surgical interventions for cerebral aneurysms annually increased.
Assuntos
Aneurisma Roto , Embolização Terapêutica , Procedimentos Endovasculares , Aneurisma Intracraniano , Hemorragia Subaracnóidea , Humanos , Aneurisma Intracraniano/cirurgia , Pandemias , Procedimentos Neurocirúrgicos/efeitos adversos , Procedimentos Neurocirúrgicos/métodos , Resultado do Tratamento , Embolização Terapêutica/métodos , Aneurisma Roto/cirurgia , Procedimentos Endovasculares/efeitos adversos , Procedimentos Endovasculares/métodos , Hemorragia Subaracnóidea/cirurgia , Estudos RetrospectivosRESUMO
We studied the clinical effectiveness of rehabilitation of 168 patients presenting with juvenile cerebral palsy in the form of spastic diplegia who received the comprehensive rehabilitative treatment including therapeutic physical exercises, paraffin applications, general hydromassage baths, manual massage and electrical stimulation of weakened muscles with the use of the following devices:
Assuntos
Paralisia Cerebral/fisiopatologia , Paralisia Cerebral/terapia , Terapia por Estimulação Elétrica/métodos , Tono Muscular , Músculo Esquelético/fisiopatologia , Adolescente , Banhos/métodos , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Massagem/métodosRESUMO
A mathematical model of the movement of olfactory cilia in different conditions was constructed. The realization of the model includes the development of a mechanical mathematical rheological model of the behavior of a continuous deformable medium, the development of the method of solution adapted to this problem, and obtaining a numerical solution, which takes into account different starting data. The mathematical modeling of the dynamic behavior of a deformable medium was performed using a system of equations for the dynamics of the deformable medium and the solution of the corresponding nonstationary system of equations in partial derivatives.
Assuntos
Movimento Celular , Cílios/fisiologia , Modelos Biológicos , Bulbo Olfatório/citologiaRESUMO
We studied the effects of uridine, uridine-5'-monophosphate (UMP), uridine-5'-diphosphate (UDP) and uridine-5'-triphosphate on contractility, coronary flow and heart rate in isolated perfused rat hearts under 60-minute regional ischemia of the left ventricle. All the compounds (50 mumol/l) induced a positive inotropic effect but had no effect on the heart rate. Uridine and UMP prevented the development of the contracture. UDP and especially UTP increased coronary flow. Probably, a protective effect of uridine and UMP is due to activation of myocardial glycogen synthesis while favourable effects of UDP and UTP on contractility and coronary flow are explained by their influence on P2U-receptors of cardiomyocytes. In addition, coronary dilatation induced by UDP and UTP promoted the reduction of the damaged zone.
Assuntos
Coração/efeitos dos fármacos , Isquemia Miocárdica/tratamento farmacológico , Nucleotídeos de Uracila/farmacologia , Uridina/farmacologia , Animais , Anisotropia , Circulação Coronária/efeitos dos fármacos , Coração/fisiopatologia , Frequência Cardíaca/efeitos dos fármacos , Técnicas In Vitro , Masculino , Contração Miocárdica/efeitos dos fármacos , Isquemia Miocárdica/metabolismo , Ratos , Nucleotídeos de Uracila/metabolismoRESUMO
Occlusion of the left coronary artery in rats provoked ventricular tachycardia (VT) and ventricular fibrillation (VF) within the first 30 min of ischemia leading to death in 20% animals. Methacin (i.v., 100 micrograms/kg) significantly prolonged VT and VF without effects on the survival. Acetylcholine (i.v., 10 micrograms/kg/min) had no influence on VT frequency and severity but prevented VF. Rats from this group survived. The same effect was observed for neostigmine (i.v., 25 micrograms/kg). Nicotine (i.v., 2.5 micrograms/kg/min) prolonged VT episode duration but did not change frequency and severity of VF and survival. Ganglioblockers hexametony and azametony (i.v., both in a dose 500 micrograms/kg) significantly attenuated VT, prevented VF and death of the animals. Thus, cholinotropic drugs may have both antiarrhythmic and proarrhythmogenic effects in early arrhythmias induced by ischemia.
Assuntos
Arritmias Cardíacas/induzido quimicamente , Arritmias Cardíacas/prevenção & controle , Colinérgicos/farmacologia , Isquemia Miocárdica/complicações , Acetilcolina/farmacologia , Animais , Inibidores da Colinesterase/farmacologia , Bloqueadores Ganglionares/farmacologia , Hexametônio/farmacologia , Masculino , Antagonistas Muscarínicos/farmacologia , Isquemia Miocárdica/tratamento farmacológico , Isquemia Miocárdica/fisiopatologia , Neostigmina/farmacologia , Nicotina/farmacologia , Oxifenônio/farmacologia , Compostos de Amônio Quaternário/farmacologia , Ratos , Taquicardia/induzido quimicamente , Fibrilação Ventricular/induzido quimicamenteRESUMO
Uridine and uridine-5'-monophosphate prevent myocardial stunning during postischemic reperfusion of isolated rat heart. Uridine-5'-diphosphate does not prevent postischemic myocardial dysfunction, while uridine-5'-triphosphate aggravates it.
Assuntos
Isquemia Miocárdica/complicações , Reperfusão Miocárdica , Miocárdio Atordoado/tratamento farmacológico , Uridina/farmacologia , Animais , Animais não Endogâmicos , Circulação Coronária/efeitos dos fármacos , Ventrículos do Coração/efeitos dos fármacos , Técnicas In Vitro , Masculino , Contração Miocárdica/efeitos dos fármacos , Miocárdio Atordoado/etiologia , Ratos , Difosfato de Uridina/farmacologia , Uridina Monofosfato/farmacologia , Uridina Trifosfato/farmacologiaRESUMO
The study of an anti-ischemic action of a new phenilalkyl taurin derivative TAU-60 has discovered that this drug attenuates ECG signs of myocardial infarction and reduces the size of necrosis zone on the anterior wall of the left ventricular myocardium in rats with experimental myocardial infarction.
Assuntos
Fármacos Cardiovasculares/uso terapêutico , Coração/efeitos dos fármacos , Infarto do Miocárdio/tratamento farmacológico , Miocárdio/patologia , Taurina/análogos & derivados , Taurina/uso terapêutico , Animais , Avaliação Pré-Clínica de Medicamentos , Eletrocardiografia/efeitos dos fármacos , Coração/fisiopatologia , Masculino , Infarto do Miocárdio/patologia , Infarto do Miocárdio/fisiopatologia , Necrose , Ratos , Oxibato de Sódio/uso terapêuticoRESUMO
The authors studied the effect of m-cholino-, adreno-, and purinotropic agents on the development of postischemic reperfusion fibrillation of isolated rat hearts. Pilocarpine, norepinephrine, phenylephrine, and adenosine caused a proarrhythmogenic effect. Atropine, trimedoxim, prazosin, and chloroquine made fibrillation less expressed. A direct correlation was found between the arrhythmogenic effect of reperfusion and the size of the no-reflow zone, with the use of the drugs too. It is concluded that the phospholipid mechanism contributes to realization of the arrhythmogenic effect of reperfusion and vascular disorders, leading to the occurrence of the no-reflow phenomenon.
Assuntos
Coração/fisiopatologia , Isquemia Miocárdica/complicações , Traumatismo por Reperfusão Miocárdica/complicações , Receptores Adrenérgicos/fisiologia , Receptores Muscarínicos/fisiologia , Receptores Purinérgicos P1/fisiologia , Fibrilação Ventricular/etiologia , Agonistas Adrenérgicos/farmacologia , Antagonistas Adrenérgicos/farmacologia , Animais , Coração/efeitos dos fármacos , Técnicas In Vitro , Masculino , Agonistas Muscarínicos/farmacologia , Antagonistas Muscarínicos/farmacologia , Isquemia Miocárdica/fisiopatologia , Traumatismo por Reperfusão Miocárdica/fisiopatologia , Agonistas do Receptor Purinérgico P1 , Antagonistas de Receptores Purinérgicos P1 , Ratos , Receptores Adrenérgicos/efeitos dos fármacos , Receptores Muscarínicos/efeitos dos fármacos , Receptores Purinérgicos P1/efeitos dos fármacos , Fatores de Tempo , Fibrilação Ventricular/fisiopatologiaRESUMO
Administration of adenosine increased the RR interval in greater degree at hyper- than in hypodynamic blood circulation type. The AV-blockade and atrial flutter were maximal in rats with hyperdynamic type of blood circulation. Propranolol weakened the adenosine cardiotropic effect whereas cholinoblockators enhanced it. Neurohumoral regulation exerted no effect on the adenosine hypotensive action.
Assuntos
Adenosina/farmacologia , Anti-Hipertensivos/farmacologia , Circulação Sanguínea/fisiologia , Fármacos Cardiovasculares/farmacologia , Adenosina/toxicidade , Animais , Fibrilação Atrial/induzido quimicamente , Fibrilação Atrial/fisiopatologia , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Fármacos Cardiovasculares/toxicidade , Eletroencefalografia , Bloqueio Cardíaco/induzido quimicamente , Bloqueio Cardíaco/fisiopatologia , Frequência Cardíaca/efeitos dos fármacos , Frequência Cardíaca/fisiologia , Masculino , RatosRESUMO
The pharmacokinetics of the effective peripheral vasodilator adenosine in blood serum of rats was studied after its intravenous injection. The dynamics of labeled adenosine in blood was described by means of a one-compartment mathematical model. The pharmacokinetic parameters of the drug were calculated from the model coefficients. The distribution of the label of adenosine and its metabolites in blood serum and heart, liver, and kidney tissues was studied by thin-layer chromatography.
Assuntos
Adenosina/farmacocinética , Vasodilatadores/farmacocinética , Adenosina/análise , Animais , Cromatografia em Camada Delgada , Feminino , Fosforilação , Ratos , Contagem de Cintilação , Análise Espectral , Fatores de Tempo , Trítio , Vasodilatadores/análiseRESUMO
The Langendorf isolated rat hearts underwent 30-minute total ischemia followed by 60-minute reperfusion. Adenosine, inosine or guanosine was added at a concentration of 50 mumol/l into the perfusate in the first 30 minutes. The nucleotides significantly increased the developed pressure and the maximum left ventricular contractility rate. The most effective agent was adenosine which also made blood flow higher. Guanosine was more effective than adenosine and inosine in protecting the heart from ischemic contracture. At the same time adenosine augmented the arrhythmogenic effect of reperfusion, by significantly elevating the cardiac levels of diene conjugates and malonic dialdehyde. It is suggested that the arrhythmogenic effect of adenosine is the result of activated lipid peroxidation due to adenosine exchange via the xanthine reaction during nucleotide-induced vasodilation.
Assuntos
Contração Miocárdica/efeitos dos fármacos , Traumatismo por Reperfusão Miocárdica/fisiopatologia , Nucleosídeos de Purina/farmacologia , Animais , Técnicas In Vitro , Masculino , Traumatismo por Reperfusão Miocárdica/tratamento farmacológico , RatosRESUMO
It has been shown that 30 min ischemia followed by 30 min reperfusion inhibits cardiac contractility. The addition of adenosine at a concentration of 50 or 100 mumol/l into the perfusate normalized a decreased cardiac contractility and prevented the onset of contracture.
Assuntos
Adenosina/uso terapêutico , Contração Miocárdica/efeitos dos fármacos , Isquemia Miocárdica/terapia , Reperfusão Miocárdica , Animais , Feminino , Contração Miocárdica/fisiologia , Isquemia Miocárdica/fisiopatologia , RatosRESUMO
The rat hearts were subjected to 60-min ischemia by left coronary artery ligation followed by 60-min reperfusion, involving intravenous adenosine inosine or guanosine given in a dose of 1 mg/kg.min-1 in the first 30 minutes of reperfusion. Ischemia and subsequent reperfusion caused a progressive decrease in cardiac output and coronary blood flow. Adenosine was found to enhance coronary blood flow and increase cardiac and stroke outputs. Inosine produced nearly the same, but less pronounced effect. Guanosine increased cardiac output without changing coronary blood flow.
Assuntos
Hemodinâmica/efeitos dos fármacos , Traumatismo por Reperfusão Miocárdica/tratamento farmacológico , Nucleosídeos de Purina/farmacologia , Animais , Débito Cardíaco/efeitos dos fármacos , Circulação Coronária/efeitos dos fármacos , Masculino , Traumatismo por Reperfusão Miocárdica/fisiopatologia , Nucleosídeos de Purina/uso terapêutico , RatosRESUMO
Correction of the lipid peroxidation rate using essential phospholipids was studied. The phospholipids were used in protection of heart tissue in experimental posthypoxic reoxygenation. Administration of essential phospholipids into the rats during myocardium reoxygenation led to an increase in activity of superoxide dismutase. The drugs containing essential phospholipids may be used in clinical practice for treatment of the impairments when elevated lipid peroxidation occurred.
Assuntos
Antioxidantes/farmacologia , Coração/efeitos dos fármacos , Hipóxia/tratamento farmacológico , Peroxidação de Lipídeos/efeitos dos fármacos , Miocárdio/metabolismo , Oxigênio/uso terapêutico , Fosfolipídeos/farmacologia , Animais , Humanos , Masculino , Ratos , Superóxido Dismutase/metabolismoRESUMO
The authors studied prophylactic action of adenosine analogs during ischemic liver damage. Hepatoprotective action of adenosine analogs was established.
Assuntos
Adenosina/análogos & derivados , Isquemia/prevenção & controle , Fígado/irrigação sanguínea , Doença Aguda , Adenosina/uso terapêutico , Animais , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Hipóxia/tratamento farmacológico , Hipóxia/metabolismo , Isquemia/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , RatosAssuntos
Adenosina/farmacologia , Infarto do Miocárdio/sangue , Agregação Plaquetária/efeitos dos fármacos , Prostaglandinas/sangue , Adenosina/uso terapêutico , Animais , Dinoprostona/sangue , Masculino , Infarto do Miocárdio/tratamento farmacológico , Coelhos , Tromboxano B2/sangue , Fatores de TempoRESUMO
Ten days course of 5'-GMP intramuscular administration at a dose of 25 mg/kg into rats with adrenaline-produced myocarditis led to normalization of NAD content in myocardial tissue which contributed to restoration of NAD-dependent isocitrate dehydrogenase activity. During the 5'-GMP administration content of ATP and creatine phosphate was kept at the same low level as compared with controls, while restoration of glycogen content was retarded in the heart muscle. Activity of lactate dehydrogenase and lactic acid content were not altered. The decrease in content of pyruvic acid detected in response to 5'-GMP administration may occur due to elevated decarboxylation of pyruvate as a result of NAD content increase in heart muscle.
Assuntos
Metabolismo Energético/efeitos dos fármacos , Guanosina Monofosfato/farmacologia , Miocardite/metabolismo , Miocárdio/metabolismo , Animais , Epinefrina , Coração/efeitos dos fármacos , Lactatos/metabolismo , Ácido Láctico , Masculino , Miocardite/induzido quimicamente , Miocárdio/enzimologia , NAD/metabolismo , Piruvatos/metabolismo , Ácido Pirúvico , RatosAssuntos
Guanina/uso terapêutico , Guanina/análogos & derivados , Guanina/síntese química , Nucleotídeos de Guanina/síntese química , Nucleotídeos de Guanina/uso terapêutico , Guanosina/análogos & derivados , Guanosina/síntese química , Guanosina/uso terapêutico , Humanos , Métodos , Ácidos Nucleicos/síntese química , Ácidos Nucleicos/uso terapêutico , RNA Fúngico/biossíntese , RNA Fúngico/síntese química , RNA Fúngico/uso terapêuticoRESUMO
The influence of adenosine on hemodynamic changes induced by electrostimulation of reflexogenic zone of aorta was studied in this article. It was shown that 3-hour electrostimulation increased the total peripheral resistance and decreased cardiac output and aortic pressure. Intravenous infusion of adenosine during electrostimulation led to the normalization of main indices of hemodynamics.
Assuntos
Adenosina/uso terapêutico , Cardiopatias/tratamento farmacológico , Hemodinâmica/efeitos dos fármacos , Animais , Aorta Torácica/fisiologia , Avaliação Pré-Clínica de Medicamentos , Estimulação Elétrica/métodos , Cardiopatias/etiologia , Cardiopatias/fisiopatologia , Masculino , Coelhos , Reflexo/fisiologia , Fatores de TempoRESUMO
In rabbit experiments, adenosine was studied for its effects on the sizes of myocardial infarction and "no reflow" zones after coronary artery occlusion and reperfusion. Intravenous administration of adenosine resulted in a steady drop in blood pressure, decrease in heart rate and increase in the extent of infarction and "no reflow" zone.